bioProtonics, Inc.
BioProtonics is a pioneering company focused on advancing diagnostic imaging through its Magnetic Resonance Histopathology (MRH) technology. MRH offers a non-invasive, high-resolution method for analyzing tissue microarchitecture during routine MRI scans. MRH
Funding history
About bioProtonics, Inc.
How much funding has bioProtonics, Inc. raised?
bioProtonics, Inc. has raised $7.3M in total funding. The most recent round was Series A.
Where is bioProtonics, Inc. headquartered?
bioProtonics, Inc. is headquartered in Santa Barbara, CA.
What does bioProtonics, Inc. do?
BioProtonics is a pioneering company focused on advancing diagnostic imaging through its Magnetic Resonance Histopathology (MRH) technology. MRH offers a non-invasive, high-resolution method for analyzing tissue microarchitecture during routine MRI scans. MRH
What problem does bioProtonics, Inc. solve?
Detecting early-stage disease and cancer typically requires costly, invasive surgical biopsies, and the site notes up to 40% false-negative rates with prostate biopsies.
What's bioProtonics, Inc.'s solution?
bioProtonics offers Magnetic Resonance Histopathology (MRH), a software-based MRI method that non-invasively measures micro-level tissue texture and pairs it with AI analysis to act as a 'digital biopsy,' aiming to replace or reduce reliance on surgical biopsies.
What makes bioProtonics, Inc. different?
The company cites a proprietary MRI pulse sequence targeting specific spatial wavelengths, full DICOM protocol compatibility for integration with existing imaging workflows, and adding as little as 90 seconds to a standard MRI scan.
What makes bioProtonics, Inc. notable?
bioProtonics appointed medical-device executive A. Burton Tripathi as CEO in June 2026 alongside a successful bridge financing round; PitchBook lists the U.S. National Science Foundation among its investors.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.